<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02380183</url>
  </required_header>
  <id_info>
    <org_study_id>2014-3414</org_study_id>
    <nct_id>NCT02380183</nct_id>
  </id_info>
  <brief_title>Needle-Guided vs Free-Hand Technique in Performing Brachial Plexus Blockade</brief_title>
  <official_title>A Randomized Controlled Study Comparing Needle-Guided vs Free-Hand Technique in Performing Brachial Plexus Blockade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CIVCO Medical Solutions</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an openly randomized controlled parallel group study evaluating the effectiveness of
      using a guided approach and free-hand approach in performing upper extremity regional blocks.
      Potential subjects for this study are the patients who are scheduled for upper extremity
      surgeries requiring supraclavicular and interscalene brachial plexus blocks at Montefiore
      Medical Center.

      Rotating residents who are participating in the study will be randomly assigned either to
      perform block under guided approach (with the help of needle guidance) or free-hand without
      the needle guidance. All the blocks will be single injection blocks utilizing the in-plane
      technique for needle insertion which is the usual protocol in our institution. Each resident
      will be performing one interscalene block with the device and one without the device and one
      supraclavicular block with device and one without the device. An independent observer will be
      present during the case and will be responsible for recording the time taken to perform the
      block, number of times the needle has been redirected and the number of times the needle is
      reinserted. This observer will also administer the satisfaction questionnaire. Number of time
      needle is redirected and number of times reinserted is also a self reported assessment by the
      physician who is performing the block. Efficacy of the block will be assessed by the standard
      of care practiced at our center.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives

        1. The primary end point of the study is to evaluate the time taken to complete blocks with
           and without the use of the needle guidance device. (Start time is considered as the
           first skin touch by the needle until the completion of the block. Completion of the
           block is defined as withdrawing the needle completely out of the body). The principal
           investigator/co-investigator and an independent observer will be recording the time
           taken to complete the block.

        2. Ease of the technique- (Will be assessed with a short questionnaire survey at the end of
           the procedure). Immediately after the block is finished, the performing physician will
           be requested to fill out the questionnaire.

        3. Number of times needle needs to be re-directed. This is self a reported measurement. The
           person performing the block, investigators (attending physician) and an independent
           observer will be recording number of times the needle was manipulated.

        4. Number of times needle was pulled out entirely out of the body and reinserted. This is
           also a self reported measurement.

        5. Efficacy of the blocks performed will be assessed (This is part of the routine standard
           of care assessing the blocks.)

        6. Total amount of time taken to complete the whole procedure (Starting from the first time
           the ultrasound probe was placed on the patient to the withdrawal of the needle after
           completing the procedure)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Needle Time;</measure>
    <time_frame>Needle insertion to needle withdrawal, up to 20 minutes</time_frame>
    <description>needle insertion to needle withdrawal</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nerve Block Procedure Time</measure>
    <time_frame>time from ultrasound contact with skin to needle withdrawal, up to 20 minutes</time_frame>
    <description>How long the procedure takes in minutes, starting from ultrasound contact with skin to needle withdrawal.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Needle Guidance; Nerve Blocks</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Civco needle guidance device will be used while the nerve block is performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Needle guidance device will not be used while nerve block is performed; nerve block is performed by hand alone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Civco Needle Guidance Device</intervention_name>
    <description>Needle guidance device will be used while nerve block is performed.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years old

          -  ASA 1-3 for upper extremity surgery receiving interscalene or supraclavicular blockade

          -  Able to understand and sign the informed consent

        Exclusion Criteria:

          -  Patient refusal of regional anesthesia

          -  Any contraindications to regional anesthesia

          -  Any anatomical or neurological disorders (also applicable to the diagnosis made by the
             anesthesiologist prior to randomization of the patient)

          -  Any other condition /diagnosis by the anesthesiologist that could compromise
             performing the block
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amaresh Vydyanathan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>January 30, 2015</study_first_submitted>
  <study_first_submitted_qc>March 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2015</study_first_posted>
  <results_first_submitted>March 3, 2018</results_first_submitted>
  <results_first_submitted_qc>February 19, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">March 12, 2019</results_first_posted>
  <last_update_submitted>February 19, 2019</last_update_submitted>
  <last_update_submitted_qc>February 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Amaresh Vydynathan</investigator_full_name>
    <investigator_title>Assoc. Prof. Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>anesthesia</keyword>
  <keyword>nerve block</keyword>
  <keyword>needle guidance</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intervention</title>
          <description>Civco needle guidance device will be used while the nerve block is performed.
Civco Needle Guidance Device: Needle guidance device will be used while nerve block is performed.</description>
        </group>
        <group group_id="P2">
          <title>Standard of Care</title>
          <description>Needle guidance device will not be used while nerve block is performed; nerve block is performed by hand alone.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intervention</title>
          <description>Civco needle guidance device will be used while the nerve block is performed.
Civco Needle Guidance Device: Needle guidance device will be used while nerve block is performed.</description>
        </group>
        <group group_id="B2">
          <title>Standard of Care</title>
          <description>Needle guidance device will not be used while nerve block is performed; nerve block is performed by hand alone.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="70"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="36"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56" lower_limit="41" upper_limit="71"/>
                    <measurement group_id="B2" value="50" lower_limit="34" upper_limit="66"/>
                    <measurement group_id="B3" value="53" lower_limit="34" upper_limit="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="36"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="36"/>
                    <count group_id="B2" value="34"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Needle Time;</title>
        <description>needle insertion to needle withdrawal</description>
        <time_frame>Needle insertion to needle withdrawal, up to 20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Civco needle guidance device will be used while the nerve block is performed.
Civco Needle Guidance Device: Needle guidance device will be used while nerve block is performed.</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Needle guidance device will not be used while nerve block is performed; nerve block is performed by hand alone.</description>
          </group>
        </group_list>
        <measure>
          <title>Needle Time;</title>
          <description>needle insertion to needle withdrawal</description>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106" lower_limit="92" upper_limit="162"/>
                    <measurement group_id="O2" value="197" lower_limit="140" upper_limit="278"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nerve Block Procedure Time</title>
        <description>How long the procedure takes in minutes, starting from ultrasound contact with skin to needle withdrawal.</description>
        <time_frame>time from ultrasound contact with skin to needle withdrawal, up to 20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Civco needle guidance device will be used while the nerve block is performed.
Civco Needle Guidance Device: Needle guidance device will be used while nerve block is performed.</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Needle guidance device will not be used while nerve block is performed; nerve block is performed by hand alone.</description>
          </group>
        </group_list>
        <measure>
          <title>Nerve Block Procedure Time</title>
          <description>How long the procedure takes in minutes, starting from ultrasound contact with skin to needle withdrawal.</description>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86" lower_limit="76" upper_limit="146"/>
                    <measurement group_id="O2" value="126" lower_limit="94" upper_limit="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>There were no adverse events reported throughout the duration of our study.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Intervention</title>
          <description>Civco needle guidance device will be used while the nerve block is performed.
Civco Needle Guidance Device: Needle guidance device will be used while nerve block is performed.</description>
        </group>
        <group group_id="E2">
          <title>Standard of Care</title>
          <description>Needle guidance device will not be used while nerve block is performed; nerve block is performed by hand alone.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>A limitation of this study was that most of the clinicians using the device were either senior residents (CA-3’s), or fellows. It is possible that this device could provide more or less benefit in newer trainees.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Amaresh Vydynathan</name_or_title>
      <organization>Montefiore Medical Center</organization>
      <phone>718-920-4316</phone>
      <email>avydynathan@montefiore.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

